R859C (p.Arg859Cys) variant of SCN1A (Nav1.1)
R859C (p.Arg859Cys) in SCN1A (Nav1.1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of SCN1A-related disorder; Early-infantile DEE; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.83 / 1. The record also includes population frequency data, published literature, and structural context.
R859C (p.Arg859Cys) variant details
- p.Arg859Cys
- rs121918784
- ClinGen CA266104
- NCI-TCGA Cosmic COSV5768
- cosmic curated COSV57681
- Pathogenic
- SCN1A-related disorder; Early-infantile DEE; not provided
- Missense
- Variant Prioritization Score for Impact Estimate 0.83
- CADD 32.00
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Pathogenic (SCN1A-related disorder; Early-infantile DEE; not provided)
- EBI: Pathogenic (in GEFSP2 and DRVT)
- UniProt: Pathogenic (in GEFSP2 and DRVT)
- Most common in the Ashkenazi Jewish population (allele frequency 7.7e-05)
- Structural context available
- Cited in: An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability. (PMID 16525050)
- Cited in: Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. (PMID 18930999)